高血压管理的最新进展
Recent advances in the management of hypertension.
作者信息
García-Donaire José Antonio, Ruilope Luis M
机构信息
Hypertension Unit Hospital 12 de Octubre, 28041, Madrid Spain.
出版信息
F1000 Med Rep. 2010 Mar 15;2:19. doi: 10.3410/M2-19.
Abstract
Recently, there have been several reports related to the adequacy of blood pressure (BP) control in high-risk hypertensive patients. These aspects have been reviewed in the recently published reappraisal of the European Society of Hypertension guidelines, and this short review comments on and briefly extends the discussion of this situation. In summary, a low BP goal when cardiorenal disease is advanced can be risky. However, attaining normal BP levels at earlier stages in the cardiorenal continuum is probably totally adequate.
摘要
最近，有几篇关于高危高血压患者血压（BP）控制是否达标的报告。欧洲高血压学会指南的最新重新评估中已对这些方面进行了综述，本简短综述对这种情况进行评论并简要拓展讨论。总之，当心肾疾病进展时设定较低的血压目标可能存在风险。然而，在心肾疾病进程的早期阶段将血压控制在正常水平可能是完全合适的。
相似文献
1
Recent advances in the management of hypertension.高血压管理的最新进展
F1000 Med Rep. 2010 Mar 15;2:19. doi: 10.3410/M2-19.
2
New ADVANCEs in guidelines.指南中的新进展。
J Hypertens Suppl. 2008 Jun;26(2):S16-8. doi: 10.1097/01.hjh.0000320755.15862.b2.
3
2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.台湾心脏病学会与台湾高血压学会2015年高血压管理指南。
J Chin Med Assoc. 2015 Jan;78(1):1-47. doi: 10.1016/j.jcma.2014.11.005. Epub 2014 Dec 26.
4
Treatment of Hypertension: Which Goal for Which Patient?高血压的治疗：针对不同患者应设定何种目标？
Adv Exp Med Biol. 2017;956:117-127. doi: 10.1007/5584_2016_97.
5
Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study.评估 CKD 高血压患者治疗期间的诊室和动态血压记录及结局：一项多中心前瞻性队列研究。
Am J Kidney Dis. 2014 Nov;64(5):744-52. doi: 10.1053/j.ajkd.2014.06.014. Epub 2014 Jul 28.
6
[Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension].[关于欧洲心脏病学会（ESC）和欧洲高血压学会（ESH）2018年动脉高血压管理指南的评论]
Internist (Berl). 2019 Apr;60(4):424-430. doi: 10.1007/s00108-019-0576-9.
7
Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure.正常至高血压人群的管理计划：先前定义为“正常高值血压”人群的降压药物治疗的风险和获益。
Korean J Intern Med. 2019 Jan;34(1):44-49. doi: 10.3904/kjim.2018.382. Epub 2018 Dec 28.
8
9
Updated Reasons and Clinical Implications of New Korean Hypertension Guidelines for Cardiologists.韩国高血压新指南对心脏病专家的更新理由及临床意义
Korean Circ J. 2020 Jun;50(6):476-484. doi: 10.4070/kcj.2019.0338. Epub 2020 Feb 29.
10
Hong Kong College of Physicians Position Statement and Recommendations on the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension.香港内科医学院关于2017年美国心脏病学会/美国心脏协会以及2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南的立场声明及建议
Hong Kong Med J. 2020 Oct;26(5):432-437. doi: 10.12809/hkmj198330.
本文引用的文献
1
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.欧洲高血压管理指南重新评估：欧洲高血压学会特别工作组文件
Blood Press. 2009;18(6):308-47. doi: 10.3109/08037050903450468.
2
Discrepancies between office and ambulatory blood pressure: clinical implications.诊室血压与动态血压差值：临床意义。
Am J Med. 2009 Dec;122(12):1136-41. doi: 10.1016/j.amjmed.2009.05.020.
3
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.在正在进行的替米沙坦单药及与雷米普利联合应用全球终点试验研究中，血压对高血管风险患者的预后价值。
J Hypertens. 2009 Jul;27(7):1360-9. doi: 10.1097/HJH.0b013e32832d7370.
4
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients.高血压患者昼夜血压模式的患病率及相关因素。
Hypertension. 2009 Mar;53(3):466-72. doi: 10.1161/HYPERTENSIONAHA.108.124008. Epub 2009 Jan 26.
5
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.贝那普利联合氨氯地平或氢氯噻嗪用于高危患者高血压的治疗
N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182.
6
Gender differences in office and ambulatory control of hypertension.高血压门诊及动态血压控制中的性别差异
Am J Med. 2008 Dec;121(12):1078-84. doi: 10.1016/j.amjmed.2008.06.037.
7
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.血管紧张素受体阻滞剂替米沙坦对不耐受血管紧张素转换酶抑制剂的高危患者心血管事件的影响：一项随机对照试验。
Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29.
8
Telmisartan to prevent recurrent stroke and cardiovascular events.替米沙坦预防复发性中风和心血管事件。
N Engl J Med. 2008 Sep 18;359(12):1225-37. doi: 10.1056/NEJMoa0804593. Epub 2008 Aug 27.
9
Telmisartan, ramipril, or both in patients at high risk for vascular events.替米沙坦、雷米普利或两者联合用于血管事件高危患者。
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
10
Treatment of hypertension in patients 80 years of age or older.80岁及以上患者的高血压治疗
N Engl J Med. 2008 May 1;358(18):1887-98. doi: 10.1056/NEJMoa0801369. Epub 2008 Mar 31.
Zotero 插件